For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Buscar Close Search
Buscar Close Search
Page Menu

UMass Chan Medical School strives to catalyze our world-class basic research into scientific discoveries with high impact clinical applications and overcome the barriers in translating knowledge into clinical practice.

Established in 1970, UMass Chan has rapidly grown into a highly productive, highly collaborative research enterprise with outstanding scientific resources and facilities. UMass Chan receives more than $300 million per year in research funding. Our research community includes a Nobel laureate, a Lasker award recipient, seven National Academy members and four Howard Hughes Medical Institute investigators. Our research achievements have impacted the lives of children and adults in the U.S. and across the globe.

Research news

Getting Results…
  • Trio of UMass Chan researchers receive awards for studies on age-related macular degeneration
    Research News

    Trio of UMass Chan researchers receive awards for studies on age-related macular degeneration

    Claudio Punzo, PhD; Johanna Seddon, MD, ScM; and Shun-Yun Cheng, PhD’22, are receiving awards from the American Macular Degeneration Foundation.

    Read more
  • UMass Chan neurobiologist Eviatar Yemini recognized with Hypothesis Fund award
    Research News

    UMass Chan neurobiologist Eviatar Yemini recognized with Hypothesis Fund award

    Eviatar Yemini, PhD, was chosen to receive a seed grant from the Hypothesis Fund, an innovative, new nonprofit that relies on a network of scientist “scouts” to identify and recommend novel, early-stage research to fund.

    Read more
  • UMass Chan researchers contribute to study of drug prevalence among injured road users
    Research News

    UMass Chan researchers contribute to study of drug prevalence among injured road users

    Kavita Babu, MD, was a co-author of a recent study from the National Highway Traffic Safety Administration on toxicological analyses of blood specimens from roadway users who were seriously or fatally injured in motor vehicle crashes.

    Read more
  • Susan Swain receives grant to explore harnessing B cells for a universal flu vaccine for older adults
    Research News

    Susan Swain receives grant to explore harnessing B cells for a universal flu vaccine for older adults

    The goal of research by Susan Swain, PhD, is to ultimately provide a blueprint for a vaccine that would recognize evolving influenza strains and provide long-lasting immunity to people throughout the life cycle, particularly among older adults, whose immune responses become weaker as they age.

    Read more
  • UMass Chan licenses rights to spinal muscular atrophy gene therapy program to CANbridge Pharmaceuticals
    Research News

    UMass Chan licenses rights to spinal muscular atrophy gene therapy program to CANbridge Pharmaceuticals

    UMass Chan Medical School has licensed the rights to develop and commercialize a novel second-generation gene therapy to treat spinal muscular atrophy developed by Jun Xie, PhD, Guangping Gao, PhD, and colleagues to global biopharmaceutical company CANbridge Pharmaceuticals Inc.

    Read more
  • UMass Chan to participate in pilot COVID-19 telehealth program Home Test to Treat launched by NIH
    Research News

    UMass Chan to participate in pilot COVID-19 telehealth program Home Test to Treat launched by NIH

    UMass Chan Medical School will evaluate the NIH’s new Home Test to Treat program that will provide free COVID-19 health services—at-home rapid tests, telehealth sessions and at-home treatments—in selected communities across the country.

    Read more